Self-Assessment and Performance in Practice Modules

Presented by The American Headache Society

American Headache Society's® Comprehensive Migraine Education Program (CMEP)
Self-Assessment and Performance in Practice Modules

Welcome to the American Headache Society’s® Self-Assessment and Performance in Practice (PIP) Modules.

Self-Assessment and Performance in Practice (PIP) activities are required for the American Board of Psychiatry and Neurology (ABPN) Maintenance of Certification. Self-Assessment activities cover knowledge and/or “best-practices” in one or more competency areas and provide feedback that can be used as the basis for focused Continuing Medical Education (CME), lifelong learning, and/or career development. PIP is a quality improvement activity for “clinically-active” physicians to assess their current practice patterns, compare those practice patterns to a set of “best-practices”, participate in educational activities to improve one’s practice, and then re-evaluate one’s practice following the educational interventions.

These PIP and Self-Assessment modules focus on migraine, with a special focus on chronic migraine. Migraine is a common neurologic disorder affecting 18% of women and 6% of men in the United States. Long considered a chronic disorder with a stable course, recent research demonstrates that in a subgroup, migraine progresses from a pattern of less frequent headaches (termed ‘episodic migraine’) to very frequent headaches (termed ‘chronic migraine’); a condition with a population prevalence of about 2%. These Self-Assessment and PIP modules aim to assess your knowledge and clinical performance regarding the diagnosis and treatment of migraine patients, and then provide educational activities aimed at enhancing your knowledge-base and clinical skills.

The entire activity (Self Assessment and Performance in Practice Modules) will take about 22 hours of your time, commensurate with the total number of CME credits provided.

Assessment and education cover the following topics:

  • Secondary Headaches
  • Diagnosing Primary Headaches
  • Medication Overuse
  • Migraine Co-Morbidities
  • Headache-Related Disability
  • Acute Treatment of Migraine
  • Prophylactic Treatment of Migraine
  • Migraine Triggers
  • Non-Pharmacologic Treatment of Migraine
  • Quantitative Assessment of Headache Patterns

The Self-Assessment module consists of 25 multiple choice questions about migraine and related disorders. After completing the test, you will be provided with the correct answers and links to educational materials pertinent to each question.

The PIP module consists of three stages:

  • Stage A – Initial Assessment

    Collect and enter data from 10 of your patients who presented with a chief complaint of headache and were diagnosed with migraine. Receive feedback regarding your performance in evaluating and treating these patients.
  • Stage B – Educational Interventions

    Education will include lectures, videos, podcasts, published papers, and links to resources that you can use with your patients. Complete recommended educational interventions within 3 months of completing Stage A.
  • Stage C – Follow-Up Assessment

    Complete this stage within 3 months of completing stage B. Collect and enter data from 10 of your patients who presented with a chief complaint of headache and were diagnosed with migraine. These patients must have been evaluated after completion of Stage B. Receive feedback regarding your performance in evaluating and treating these patients.

Curriculum Developers

Richard Lipton, MD, FAHS
Professor and Vice Chair of Neurology
Professor of Epidemiology and Population Health
Albert Einstein College of Medicine
Bronx, NY

Todd J. Schwedt, MD, FAHS
Associate Professor
Department of Neurology
Mayo Clinic Arizona
Phoenix, AZ

Curriculum Developer Disclosures

Richard B. Lipton, MD, FAHS - Dr. Lipton receives research support from the NIH- PO1 AG03949 (Program Director), PO1AG027734 (Project Leader), RO1AG025119 (Investigator), K23AGO30857 (Mentor), K23NS05140901A1 (Mentor), and K23NS47256 (Mentor), the National Headache Foundation and the Migraine Research Fund; serves on the editorial boards of Neurology and Cephalalgia and as senior advisor to Headache, has reviewed for the NIA and NINDS, holds stock options in Neuralieve Inc, and Minster INC; serves as a consultant or has received honoraria from: Allergan, Autonomic Technologies, Boston Scientific, Bristol Myers Squibb, Eli Lilly, Endo, GlaxoSmithKline, Minster, Merck, Nautilus Neuroscience, Neuralieve, Novartis, and Pfizer.

Todd Schwedt, MD, FAHS - Dr. Schwedt is the recipient of research grants from AGA Medical and Merck & Co., Inc. He is on the speaker's bureau for Allergan.

Faculty

Todd J. Schwedt, MD, FAHS
Associate Professor
Department of Neurology
Mayo Clinic Arizona
Phoenix, AZ

Faculty Disclosures

Todd Schwedt, MD, FAHS - Dr. Schwedt is the recipient of research grants from AGA Medical and Merck & Co., Inc. He is on the speaker's bureau for Allergan.

Staff Disclosures

Linda McGillicuddy
Ms. McGillicuddy has nothing to disclose.

Andrea Taylor
Ms. Taylor has nothing to disclose.

Kathleen Baumer
Ms. Baumer has nothing to disclose.

Maripat Traino
Ms. Traino has nothing to disclose.

Laurie Morris
Ms. Morris has nothing to disclose.

ABPN Approved

The Comprehensive Migraine Education Program (CMEP) Performance Improvement (PICME) has been reviewed and approved by the American Board of Psychiatry and Neurology (ABPN). The approval period is for October 19, 2011 - October 19, 2014. Twenty category-1 CME credits are awarded after completion of the PIP module and two category-1 CME credits are awarded following completion of the Self-Assessment module. This project fulfills the clinical module of a Performance in Practice Unit.

Continuing Medication Education (CME) Credits

The American Headache Society® is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing education medical education for physicians. The American Headache Society takes responsibility for the content, quality, and scientific integrity of this CME activity.

The American Headache Society® designates AMA PRA Category 1 credit(s)TM for this online, web-based medical education activity, Comprehensive Migraine Education Program (CMEP)  Self-Assessment and Performance in Practice Modules. A maximum of 2 CME credits are awarded upon completion of this Self-Assessment program and a maximum of 20 CME credits are awarded upon completion of the PIP program.

Activity Start Date: October 19, 2011

Activity End Date: October 19, 2014

American Academy of Physician Assistants (AAPA)

This Performance Improvement CME program has been reviewed and is approved for a maximum of 20.00 AAPA Category 1 PI-CME credits by the Physician Assistant Review Panel. Total number of approved credits for each stage of this PI-CME program are as follows:

  • Stage A: 5.0 AAPA Category 1 PI-CME credits
  • Stage B: 5.0 AAPA Category 1 PI-CME credits
  • Stage C: 5.0 AAPA Category 1 PI-CME credits
  • Bonus for completion of all three stages: 5.0 AAPA Category 1 PI-CME credits

Approval is valid until October 19, 2014. Physician Assistants should claim only the credit commensurate with the extent of their participation in the activity. This program was planned in accordance with AAPA’s CME Standards. Please note the Self Assessment module is not approved for AAPA Category 1 Self-Assessment credits.

Note

The outcomes from these Self-Assessment and PIP modules will be collected in order to determine the effectiveness of this initiative and for development of future versions of this Self-Assessment and PIP module. Furthermore, these outcomes (in aggregate) may be reported. However, all data would be de-identified prior to reporting/publication.

Hardware/Software Requirements

Contact AHS

If you have any questions about this course please contact AHS headquarters at ahshq@talley.com or 856-423-0043.

Policy on Privacy and Confidentiality

View the American Headache Society's Policy on Privacy and Confidentiality

 

 

Supported by an educational grant from Allergan_(color)